OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An updated patent review of GLP-1 receptor agonists (2020-present)
Weiwen Lu, Zhongbo Zhou, Neng Jiang, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 9, pp. 597-612
Closed Access | Times Cited: 9
Weiwen Lu, Zhongbo Zhou, Neng Jiang, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 9, pp. 597-612
Closed Access | Times Cited: 9
Showing 9 citing articles:
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
Areesha Moiz, Kristian B. Filion, Helia Toutounchi, et al.
Annals of Internal Medicine (2025) Vol. 178, Iss. 2, pp. 199-217
Closed Access | Times Cited: 7
Areesha Moiz, Kristian B. Filion, Helia Toutounchi, et al.
Annals of Internal Medicine (2025) Vol. 178, Iss. 2, pp. 199-217
Closed Access | Times Cited: 7
Comparative Efficacy and Safety of GLP-1 Receptor Agonists for Weight reduction: A Model-Based Meta-Analysis of Placebo-Controlled Trials
Hongquan Guo, Juan Yang, Jihan Huang, et al.
Obesity Pillars (2025), pp. 100162-100162
Open Access | Times Cited: 1
Hongquan Guo, Juan Yang, Jihan Huang, et al.
Obesity Pillars (2025), pp. 100162-100162
Open Access | Times Cited: 1
Nanoparticle-based therapeutic strategies for chronic liver diseases: Advances and insights
Padmanaban Sathiyamoorthy, Jiwon Baek, Sai Sahithya Chamarthy, et al.
Liver Research (2025)
Open Access
Padmanaban Sathiyamoorthy, Jiwon Baek, Sai Sahithya Chamarthy, et al.
Liver Research (2025)
Open Access
Advances of deep Neural Networks (DNNs) in the development of peptide drugs
Yuzhen Niu, Pingyang Qin, Ping Lin
Future Medicinal Chemistry (2025), pp. 1-15
Closed Access
Yuzhen Niu, Pingyang Qin, Ping Lin
Future Medicinal Chemistry (2025), pp. 1-15
Closed Access
Molecular mapping and functional validation of GLP-1R cholesterol binding sites in pancreatic beta cells
Affiong I Oqua, Kin Chao, Liliane El Eid, et al.
(2025)
Open Access
Affiong I Oqua, Kin Chao, Liliane El Eid, et al.
(2025)
Open Access
Molecular mapping and functional validation of GLP-1R cholesterol binding sites in pancreatic beta cells
Affiong I Oqua, Kin Chao, Liliane El Eid, et al.
(2024)
Open Access | Times Cited: 2
Affiong I Oqua, Kin Chao, Liliane El Eid, et al.
(2024)
Open Access | Times Cited: 2
Identification and utility exploration of a highly potent and long-acting bullfrog GLP-1 analogue in GLP-1 and amylin combination therapy
Xiao Sun, Dawei Yang, Y. Li, et al.
Peptides (2024) Vol. 177, pp. 171203-171203
Closed Access | Times Cited: 1
Xiao Sun, Dawei Yang, Y. Li, et al.
Peptides (2024) Vol. 177, pp. 171203-171203
Closed Access | Times Cited: 1
Molecular mapping and functional validation of GLP-1R cholesterol binding sites in pancreatic beta cells
Affiong I Oqua, Kin Chao, Liliane El Eid, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Affiong I Oqua, Kin Chao, Liliane El Eid, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Molecular mapping and functional validation of GLP-1R cholesterol binding sites in pancreatic beta cells
Affiong I Oqua, Kin Chao, Liliane El Eid, et al.
(2024)
Open Access
Affiong I Oqua, Kin Chao, Liliane El Eid, et al.
(2024)
Open Access
